US Patent 10654831 Antiproliferative pyrimidine-based compounds
Patent 10654831 was granted and assigned to G1 Therapeutics on May, 2020 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10654831 Antiproliferative pyrimidine-based compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.